FT Vest U.S. Equity Max Buffer ETF – December (BATS:DECM – Get Free Report) saw a significant increase in short interest in the month of October. As of October 15th, there was short interest totaling 7,073 shares, an increase of 60.9% from the September 30th total of 4,397 shares. Approximately 0.6% of the shares of the company are short sold. Based on an average daily trading volume, of 2,371 shares, the days-to-cover ratio is currently 3.0 days.
FT Vest U.S. Equity Max Buffer ETF – December Price Performance
Shares of DECM stock opened at $34.37 on Monday. FT Vest U.S. Equity Max Buffer ETF – December has a 52 week low of $32.26 and a 52 week high of $34.47. The firm’s 50-day simple moving average is $34.28 and its two-hundred day simple moving average is $33.58.
Institutional Trading of FT Vest U.S. Equity Max Buffer ETF – December
A hedge fund recently bought a new stake in FT Vest U.S. Equity Max Buffer ETF – December stock. CoreCap Advisors LLC purchased a new stake in shares of FT Vest U.S. Equity Max Buffer ETF – December (BATS:DECM – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 908 shares of the company’s stock, valued at approximately $31,000. CoreCap Advisors LLC owned about 0.07% of FT Vest U.S. Equity Max Buffer ETF – December at the end of the most recent reporting period.
About FT Vest U.S. Equity Max Buffer ETF – December
The FT Vest U.S. Equity Max Buffer ETF – December (DECM) is an exchange-traded fund that mostly invests in large cap equity. The fund seeks to provide a pre-determined investment outcome over a one-year period. The exposure is reset annually in December DECM was launched on Dec 20, 2024 and is issued by First Trust.
Further Reading
- Five stocks we like better than FT Vest U.S. Equity Max Buffer ETF – December
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for FT Vest U.S. Equity Max Buffer ETF - December Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FT Vest U.S. Equity Max Buffer ETF - December and related companies with MarketBeat.com's FREE daily email newsletter.
